| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |